C16 Ceramide (d18:1/16:0) – 25 mg

Brand:
Cayman
CAS:
24696-26-2
Storage:
-20
UN-No:
Non-Hazardous - /

Ceramides are generated from sphingomyelin through activation of sphingomyelinases or through the de novo synthesis pathway, which requires coordinate action of serine palmitoyl transferase and ceramide synthase. They have been shown to mediate antiproliferative responses such as apoptosis, growth arrest, differentiation, and senescence.{19146} C16 ceramide (d18:1/16:0) is an endogenous ceramide, generated by ceramide synthase 6 (CerS6), that acts as a lipid second messenger to regulate apoptosis and stress signaling.{18796} Accumulation of C16 ceramide (d18:1/16:0) through PPMP (30 μM) or MAPP (50 μM) treatment or from addition of 100 μM synthetic C16 ceramide (d18:1/16:0) induces apoptosis in neutrophil cultures via caspase-3 activation.{19145}  

 

Available on backorder

SKU: 10681 - 25 mg Category:

Description

An endogenous ceramide, generated by ceramide synthase 6, that acts a lipid second messenger to regulate apoptosis and stress signaling


Formal name: N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-hexadecanamide

Synonyms:  Cer(d18:1/16:0)|Ceramide (d18:1/16:0)|N-Palmitoyl-D-erythro-Sphingosine|Palmitoyl Ceramide

Molecular weight: 537.9

CAS: 24696-26-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Lipid Biochemistry|Sphingolipids